2024 SV Therapeutics Impact & ESG Report
Read More
Alpheus Medical Announces Positive Phase 1/2 Trial Results for the Treatment of Recurrent High-Grade Gliomas
Data Presented at the American College of Chest Physicians Correlates Airway Remodeling with Positive Clinical Outcomes Utilizing the RejuvenAir® System
SpectraWAVE Announces $50M Series B Financing to Drive Commercial Expansion and Product Additions to the HyperVue™ Imaging System
Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors - Paul LaViolette to serve as Co-Chairman alongside Robert W. Duggan, adding 40 years of medical technology development, operating and leadership expertise
Spineology® Announces $25 Million Equity Financing – Funding to aid in acceleration of commercial growth, clinical education programs, and product development enhancements for highly-differentiated OptiMesh® implant portfolio –
Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
Endotronix Receives FDA Premarket Approval of the Cordella™ PA Sensor System for the Treatment of Heart Failure
Merck signs $3bn deal for Kate Bingham-backed eye disease biotech
Read More
SV Health Investors-created EyeBio to be acquired by MSD for up to $3 billion
Nanopath Receives $4 Million in Grants from National Institutes of Health and National Science Foundation
QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
SV News
19 July 2018SV NewsBill Gates announces new investment in Alzheimer’s research to help launch Diagnostics Accelerator
17 July 2018SV NewsKate Bingham’s 'The Moment' interview with Maxinne Mawhinney- 25 June 2018SV NewsDementia Discovery Fund Announces the Appointment of Angus Grant PhD as CEO
- 25 June 2018SV NewsThe Dementia Discovery Fund Raises $350 Million
- 19 June 2018SV NewsDDF Announce Research Collaboration with Immuneering
24 May 2018Portfolio NewsSchweiger Dermatology Group Announces $100 Million Investment from LNK Partners
4 May 2018Portfolio NewsScience 2 Startup Symposium Convened Over 230 Academic Researchers, Venture Capitalists, Entrepreneurs, and Pharmaceutical Executives, Creating Connections That Can Advance Scientific Innovation and Entrepreneurship
18 April 2018Portfolio NewsWSJ Health Forum - 22 May 2018- 12 April 2018SV NewsSV Health Investors to Co-Host Symposium Featuring Therapeutics Startup Ideas from World's Top Academic Research Institutions
- 20 February 2018SV NewsDDF welcomes recent FDA guidance which opens new paths for Alzheimer’s treatments
1 February 2018Portfolio NewsAVROBIO, Inc. Announces $60 Million Series B Financing to Advance Gene Therapy Pipeline for Lysosomal Storage Disorders and Apply Lentiviral Platform to Other Genetic Diseases- 31 January 2018Portfolio NewsBill Gates interview cites DDF investment
